DocSym
β
Searchsearch
Search
(D04.1) Carcinoma in situ: skin of eyelid, including canthus
More details coming soon
68 114 in individuals diagnosis carcinoma in situ: skin of eyelid, including canthus confirmed
1 715 deaths with diagnosis carcinoma in situ: skin of eyelid, including canthus
3% mortality rate associated with the disease carcinoma in situ: skin of eyelid, including canthus
Diagnosis carcinoma in situ: skin of eyelid, including canthus is diagnosed Women are 3.98% more likely than Men
32 700
Men receive the diagnosis carcinoma in situ: skin of eyelid, including canthus
1 180 (3.6 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
35 414
Women receive the diagnosis carcinoma in situ: skin of eyelid, including canthus
535 (1.5 %)Died from this diagnosis.
Risk Group for the Disease carcinoma in situ: skin of eyelid, including canthus - Men aged 70-74 and Women aged 80-84
In Men diagnosis is most often set at age 0-14, 20-95+
Less common in men the disease occurs at Age 0-1, 15-19Less common in women the disease occurs at Age 0-1, 20-24
In Women diagnosis is most often set at age 0-19, 25-95+
Disease Features carcinoma in situ: skin of eyelid, including canthus
Absence or low individual and public risk
Carcinoma in situ: skin of eyelid, including canthus - what does this mean
Carcinoma in situ of the skin of the eyelid, including the canthus, is a pre-cancerous condition in which abnormal cells form in the top layers of the skin. these cells are not yet invading deeper layers of the skin, but they have the potential to grow and spread to other parts of the body.
What happens during the disease - carcinoma in situ: skin of eyelid, including canthus
Carcinoma in situ of the skin of the eyelid, including the canthus, is caused by the uncontrolled growth of abnormal cells that have not spread beyond the top layer of the skin. this type of abnormal cell growth is usually caused by prolonged exposure to ultraviolet radiation, such as from the sun, or to other environmental factors, such as exposure to certain chemicals or toxins. in some cases, the cause may be unknown. carcinoma in situ of the skin of the eyelid, including the canthus, can be treated with surgery, radiation therapy, or topical medications.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Perform a physical examination of the eyelid, including the canthus, to look for any abnormal growths or discoloration of the skin.
- Perform a biopsy of the affected area to obtain a tissue sample.
- Examine the tissue sample under a microscope to look for abnormal cell growth.
- Perform a CT scan of the affected area to look for any underlying abnormalities.
- Perform an MRI scan of the affected area to look for any underlying abnormalities.
- Perform a PET scan of the affected area to look for any underlying abnormalities.
- Perform a blood test to look for any markers associated with carcinoma in situ.
Treatment and Medical Assistance
Main goal of the treatment: To remove or destroy the abnormal cells that have developed in the skin of the eyelid.
- Excisional surgery
- Cryosurgery
- Electrodessication and curettage
- Laser therapy
- Radiation therapy
- Topical chemotherapy
8 Days of Hospitalization Required
86 Hours Required for Outpatient Treatment
Carcinoma in situ: skin of eyelid, including canthus - Prevention
Carcinoma in situ of the skin of the eyelid, including the canthus, can be prevented by avoiding direct exposure to the sun, wearing sunglasses with uv protection, using sunscreen, covering up with hats and clothing, and avoiding tanning beds.